PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA)

Historical Holders from Q4 2024 to Q3 2025

Symbol
PVLA on Nasdaq
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
11,823,764
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
8,525,488
Holdings value
$534,466,075
% of all portfolios
0%
Number of holders
100
Number of buys
66
Number of sells
-26
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Kaupinen Wes 14.6% $38,555,729 1,644,869 Kaupinen Wes 13 Dec 2024
BIOTECHNOLOGY VALUE FUND L P 9.99% $74,049,052 1,181,194 BVF PARTNERS L P/IL 30 Sep 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 7.4% -13.3% $51,556,256 +$6,766,571 822,400 +15.1% SUVRETTA CAPITAL MANAGEMENT, LLC 30 Sep 2025
Frazier Life Sciences Public Fund, L.P. 4.9% -23.3% $14,434,036 -$3,823,682 545,504 -20.9% Frazier Life Sciences Public Fund, L.P. 30 Jun 2025
Samsara BioCapital, L.P. 3.1% -50% $8,989,600 -$8,989,600 339,743 -50% Samsara BioCapital, L.P. 30 Jun 2025
Dellora Investments LP 1.3% $3,306,892 141,079 Dellora Investments LP 13 Dec 2024

Institutional Holders of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 8,525,488 $534,466,075 +$183,107,977 $62.69 100
2025 Q2 5,909,706 $133,205,244 +$16,635,084 $22.54 64
2025 Q1 5,123,397 $143,404,590 +$33,701,617 $27.99 40
2024 Q4 4,033,052 $48,417,227 +$48,417,227 $12.00 32